Front and Center on CBS News: Advances in Genomic Testing

CBS News Sunday Morning, December 2, 2012

In this feature, reporter Tracy Smith provides an in-depth review of recent advances in the field of prognostic testing. Using DecisionDx-UM as a prime example, she explores the pressing question, “Would you want to know?”

Patients told CBS that it was valuable to know their odds of survival for a variety of reasons, including life-planning purposes and peace of mind. Dr. Scott Gaines, a Class II patient himself, says knowing his prognosis has changed how he’s living his life.

“I like to savor moments, savor things, smell, teach my boys to smell, remember this. Get all your senses into it,” Dr. Gaines told CBS. “Would I have done that if I was a Class I? I don’t know.”

Know your TYPE, Know your RISK
You’ve just been diagnosed with uveal melanoma, and it’s important to know that there is a test that can identify your tumor type—and the risk of your cancer spreading.

READ MORE
GETTING TESTED       Timing is Critical
To know your tumor type and risk, a biopsy must be taken BEFORE radiation treatment.

READ MORE
Talk to                 Your Doctor
Use this discussion guide to talk to your doctor about the genomic test to learn your tumor type, or CLASS.

DOWNLOAD PDF

Sign Up For Updates


Please leave this field empty.

Share on Facebook+1Share on Twitter

Share Your Stories

There's comfort in knowing you are not alone. If you or a loved one have experienced uveal melanoma and would like to help encourage others whose lives have been touched by this disease, please share your story with us.
Start Sharing
7ads6x98y